ContributorsPublishersAdvertisers

Axitinib Plus Anti-PD1 Regimen Is Effective as First-line Mucosal Melanoma Treatment

ajmc.com
 2021-10-09

Cover picture for the articleA retrospective study on the combination of a vascular endothelial growth factor receptor inhibitor plus programmed cell death-1 blockade added to evidence of efficacy in early trials. The combination of a vascular endothelial growth factor receptor (VEGFR) inhibitor and programmed cell death-1 (PD-1) antibody has shown effectiveness in early...

www.ajmc.com

Comments / 0

Comments / 0